US Stock MarketDetailed Quotes

Avenue Therapeutics (ATXI)

Watchlist
  • 0.6600
  • +0.1100+20.00%
15min DelayClose Apr 24 11:09 ET
1.36MMarket Cap-0.06P/E (TTM)

Avenue Therapeutics (ATXI) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments
10.06%2.86M
10.06%2.86M
42.82%3.71M
-32.38%3.33M
9.64%3.5M
45.49%2.59M
45.49%2.59M
1,513.04%2.6M
213.11%4.92M
-61.22%3.19M
-Cash and cash equivalents
10.06%2.86M
10.06%2.86M
42.82%3.71M
-32.38%3.33M
9.64%3.5M
45.49%2.59M
45.49%2.59M
1,513.04%2.6M
213.11%4.92M
-61.22%3.19M
Receivables
----
----
----
--800K
----
----
----
----
----
----
-Other receivables
----
----
----
--800K
----
----
----
----
----
----
Other current assets
-2.56%76K
-2.56%76K
-42.86%16K
-49.28%35K
-20.69%92K
16.42%78K
16.42%78K
55.56%28K
0.00%69K
-41.41%116K
Total current assets
9.69%2.93M
9.69%2.93M
41.90%3.73M
-16.58%4.16M
8.58%3.59M
44.43%2.67M
44.43%2.67M
422.91%2.63M
199.40%4.99M
-60.81%3.31M
Non current assets
Total non current assets
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total assets
9.69%2.93M
9.69%2.93M
41.90%3.73M
-16.58%4.16M
8.58%3.59M
44.43%2.67M
44.43%2.67M
422.91%2.63M
199.40%4.99M
-60.81%3.31M
Liabilities
Current liabilities
Payables
140.53%724K
140.53%724K
56.93%1.03M
-22.97%456K
-34.89%431K
-24.94%301K
-24.94%301K
17.32%657K
18.40%592K
77.01%662K
-accounts payable
-39.35%94K
-39.35%94K
250.00%490K
-58.85%79K
-44.19%173K
98.72%155K
98.72%155K
-52.70%140K
-56.95%192K
-6.06%310K
-Due to related parties current
331.51%630K
331.51%630K
4.64%541K
-5.75%377K
-26.70%258K
-54.80%146K
-54.80%146K
95.83%517K
640.74%400K
700.00%352K
Current accrued expenses
-59.88%193K
-59.88%193K
-4.84%236K
125.29%766K
206.58%745K
142.93%481K
142.93%481K
-73.45%248K
-73.56%340K
-94.24%243K
Other current liabilities
-93.75%1K
-93.75%1K
-93.10%2K
----
-99.76%1K
-97.27%16K
-97.27%16K
-99.12%29K
-99.20%47K
-92.78%413K
Current liabilities
34.68%1.1M
34.68%1.1M
46.15%1.42M
14.47%1.33M
-10.62%1.26M
-31.77%816K
-31.77%816K
-80.63%973K
-85.14%1.16M
-86.68%1.41M
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
34.68%1.1M
34.68%1.1M
46.15%1.42M
14.47%1.33M
-10.62%1.26M
-31.77%816K
-31.77%816K
-80.63%973K
-85.14%1.16M
-86.68%1.41M
Shareholders'equity
Share capital
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
-common stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-2.84%-105.49M
-2.84%-105.49M
-3.71%-104.78M
-6.26%-104.1M
-9.62%-104.43M
-12.81%-102.58M
-12.81%-102.58M
-10.34%-101.04M
-6.37%-97.96M
-8.15%-95.27M
Paid-in capital
1.84%107.32M
1.84%107.32M
4.53%108.34M
5.29%108.16M
10.03%107.94M
13.91%105.38M
13.91%105.38M
17.89%103.65M
18.40%102.72M
13.24%98.1M
Total stockholders'equity
-34.50%1.83M
-34.50%1.83M
36.28%3.56M
-14.82%4.06M
23.77%3.51M
76.80%2.8M
76.80%2.8M
171.51%2.61M
189.28%4.76M
295.32%2.84M
Noncontrolling interests
--0
--0
-30.90%-1.25M
-30.84%-1.23M
-25.59%-1.18M
-1.40%-941K
-1.40%-941K
-9.86%-958K
-15.68%-937K
-33.05%-938K
Total equity
-1.29%1.83M
-1.29%1.83M
39.41%2.3M
-26.00%2.83M
22.87%2.33M
183.79%1.86M
183.79%1.86M
136.53%1.65M
162.27%3.83M
187.99%1.9M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments 10.06%2.86M10.06%2.86M42.82%3.71M-32.38%3.33M9.64%3.5M45.49%2.59M45.49%2.59M1,513.04%2.6M213.11%4.92M-61.22%3.19M
-Cash and cash equivalents 10.06%2.86M10.06%2.86M42.82%3.71M-32.38%3.33M9.64%3.5M45.49%2.59M45.49%2.59M1,513.04%2.6M213.11%4.92M-61.22%3.19M
Receivables --------------800K------------------------
-Other receivables --------------800K------------------------
Other current assets -2.56%76K-2.56%76K-42.86%16K-49.28%35K-20.69%92K16.42%78K16.42%78K55.56%28K0.00%69K-41.41%116K
Total current assets 9.69%2.93M9.69%2.93M41.90%3.73M-16.58%4.16M8.58%3.59M44.43%2.67M44.43%2.67M422.91%2.63M199.40%4.99M-60.81%3.31M
Non current assets
Total non current assets --0--0--0--0--0--0--0--0--0--0
Total assets 9.69%2.93M9.69%2.93M41.90%3.73M-16.58%4.16M8.58%3.59M44.43%2.67M44.43%2.67M422.91%2.63M199.40%4.99M-60.81%3.31M
Liabilities
Current liabilities
Payables 140.53%724K140.53%724K56.93%1.03M-22.97%456K-34.89%431K-24.94%301K-24.94%301K17.32%657K18.40%592K77.01%662K
-accounts payable -39.35%94K-39.35%94K250.00%490K-58.85%79K-44.19%173K98.72%155K98.72%155K-52.70%140K-56.95%192K-6.06%310K
-Due to related parties current 331.51%630K331.51%630K4.64%541K-5.75%377K-26.70%258K-54.80%146K-54.80%146K95.83%517K640.74%400K700.00%352K
Current accrued expenses -59.88%193K-59.88%193K-4.84%236K125.29%766K206.58%745K142.93%481K142.93%481K-73.45%248K-73.56%340K-94.24%243K
Other current liabilities -93.75%1K-93.75%1K-93.10%2K-----99.76%1K-97.27%16K-97.27%16K-99.12%29K-99.20%47K-92.78%413K
Current liabilities 34.68%1.1M34.68%1.1M46.15%1.42M14.47%1.33M-10.62%1.26M-31.77%816K-31.77%816K-80.63%973K-85.14%1.16M-86.68%1.41M
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities 34.68%1.1M34.68%1.1M46.15%1.42M14.47%1.33M-10.62%1.26M-31.77%816K-31.77%816K-80.63%973K-85.14%1.16M-86.68%1.41M
Shareholders'equity
Share capital --0--0--0--0--0--0--0--0--0--0
-common stock --0--0--0--0--0--0--0--0--0--0
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -2.84%-105.49M-2.84%-105.49M-3.71%-104.78M-6.26%-104.1M-9.62%-104.43M-12.81%-102.58M-12.81%-102.58M-10.34%-101.04M-6.37%-97.96M-8.15%-95.27M
Paid-in capital 1.84%107.32M1.84%107.32M4.53%108.34M5.29%108.16M10.03%107.94M13.91%105.38M13.91%105.38M17.89%103.65M18.40%102.72M13.24%98.1M
Total stockholders'equity -34.50%1.83M-34.50%1.83M36.28%3.56M-14.82%4.06M23.77%3.51M76.80%2.8M76.80%2.8M171.51%2.61M189.28%4.76M295.32%2.84M
Noncontrolling interests --0--0-30.90%-1.25M-30.84%-1.23M-25.59%-1.18M-1.40%-941K-1.40%-941K-9.86%-958K-15.68%-937K-33.05%-938K
Total equity -1.29%1.83M-1.29%1.83M39.41%2.3M-26.00%2.83M22.87%2.33M183.79%1.86M183.79%1.86M136.53%1.65M162.27%3.83M187.99%1.9M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More